- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04080492
A Cardiac Disease Quality of Life Study (UPLIFT)
A Prospective Study to Assess Multi-Domain Patient-Reported Cardiac Quality of Life in Adults With Hypertrophic Cardiomyopathy, Thoracic Aortopathy, and Radiation-Induced Heart Disease: UPLIFT
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
While physicians and patients may be aware of the physical limitations that result from a diagnosis of hypertrophic cardiomyopathy (HCM), thoracic aortic dilatation (TAD) or radiation-induced heart disease (RIHD), there is little research on the impact on quality of life from the limitations imposed with these diagnosis. This study aims to address these unknowns in patients with HCM or TAD as well as radiation-induced heart disease in first-time patients at the Cleveland Clinic. Knowledge gained from this study will provide us the ability for better management of the chronic impacts of the disease by identifying potential risk factors of low quality of life or changes in quality of life over time.
This is a prospective, longitudinal, non-comparator, non-randomized survey study describing QOL outcomes for patients with HCM, TAD, or RIHD. Patients being seen for the first time at the Cleveland Clinic for cardiac disease with no previous or scheduled surgery for HCM or TAD will electronically complete a Cardiac Quality of Life Survey at 3 time points (baseline, 3 month & 9 month). The Cardiac Quality of Life Survey measures the participant's health status in five domains - global, physical, emotional, social, and spiritual - as well as self-efficacy and resilience.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Milind Desai, M. D.
- Phone Number: 216-445-5250
- Email: desaim2@ccf.org
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic
-
Contact:
- Milind Desai, MD
- Phone Number: 216-445-5250
- Email: Desaim2@ccf.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 18-70 at time of consent with a confirmed diagnosis of HCM, TAD, and/or RIHD being seen at CC Main Campus for a comprehensive clinical cardiac evaluation (i.e. physician, surgeon, nurse practitioner, geneticist, testing, imaging, etc) to define treatment plan for either diagnosis as per Cleveland Clinic provider.
- Patient or an individual in their social support network has the equipment (phone, computer, tablet) and internet connection to complete the emailed follow-up questionnaires.
Exclusion Criteria:
- Previously had surgery or plans to have surgery (full/mini sternotomy or endovascular) in the next nine months for HCM or TAD.
- Inability or unwillingness to comply with study requirements in the opinion of the investigator.
- Inability to provide informed consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Hypertrophic Cardiomyopathy
Patients being seen for the first time at the Cleveland Clinic for Hypertrophic Cardiomyopathy.
|
The Cardiac Quality of Life (QOL) survey measures health status in five domains: global, physical, emotional, social, and spiritual health.
It also includes questions that assess self-efficacy and resilience.
The global section asks about your overall quality of life and satisfaction with health.
The physical section asks about symptoms and difficulty performing day-to-day tasks.
The emotional section asks about depression, anxiety, and stress.
The social section asks about social support and relationships.
The spiritual section asks about the spiritual outlook on the burden of heart disease.
Responses on a 5-level scale.
|
Thoracic Aortic Dilatation
Patients being seen for the first time at the Cleveland Clinic for Thoracic Aortic Dilatation.
|
The Cardiac Quality of Life (QOL) survey measures health status in five domains: global, physical, emotional, social, and spiritual health.
It also includes questions that assess self-efficacy and resilience.
The global section asks about your overall quality of life and satisfaction with health.
The physical section asks about symptoms and difficulty performing day-to-day tasks.
The emotional section asks about depression, anxiety, and stress.
The social section asks about social support and relationships.
The spiritual section asks about the spiritual outlook on the burden of heart disease.
Responses on a 5-level scale.
|
Radiation Induced Heart Disease
Patients being seen for the first time at the Cleveland Clinic for Radiation-Induced Heart Disease.
|
The Cardiac Quality of Life (QOL) survey measures health status in five domains: global, physical, emotional, social, and spiritual health.
It also includes questions that assess self-efficacy and resilience.
The global section asks about your overall quality of life and satisfaction with health.
The physical section asks about symptoms and difficulty performing day-to-day tasks.
The emotional section asks about depression, anxiety, and stress.
The social section asks about social support and relationships.
The spiritual section asks about the spiritual outlook on the burden of heart disease.
Responses on a 5-level scale.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global domain of Cardiac Quality of Life Survey assessed 9 months after baseline as compared to baseline.
Time Frame: 9 months after baseline visit
|
The global domain of the Cardiac Quality of Life Survey assesses global health.
Three questions related to 1) Perceived overall quality of life, 2) & 3) Satisfaction with overall health status and with heart health.
The Perceived overall quality of life responses range from very poor =1 to very good =5.
2) & 3) Satisfaction responses range from very dissatisfied=1 to very satisfied=5.
Total global domain score ranges from 3 to 15 points.
The higher the score the less impact the cardiac disease has on quality of life.
|
9 months after baseline visit
|
Physical domain of Cardiac Quality of Life Survey assessed 9 months after baseline as compared to baseline
Time Frame: 9 months after baseline visit
|
The physical domain of the Cardiac Quality of Life Survey assesses physical function.
13 questions.
1) Perception of overall physical health: responses ranging from 1=very poor to 5=very good.
2-6) Difficulty performing day-to-day physical tasks with responses ranging from 1=very easy to 5=very difficult.
7-13) Severity of heart disease symptoms affecting day-to-day physical activities: responses ranging from 1=never to 5=always.
Total physical domain score ranges from 13 to 85.
The higher the score the less impact the cardiac disease has on physical health.
|
9 months after baseline visit
|
Emotional domain of Cardiac Quality of Life Survey assessed 3 months after baseline as compared to baseline.
Time Frame: 9 months after baseline visit
|
The emotional domain of the Cardiac Quality of Life Survey assesses emotional health.
23 questions. 1) Perception of overall emotional health: responses ranging from 1=very poor to 5=very good.
2) effect of heart disease-related physical limitations on emotional health: responses ranging from 1=always to 5=never.
Eight questions asking about anxiety with responses ranging from 1=always to 5=never.
Seven questions assessing depression are incorporated with responses ranging from 1=always to 5=never.
19-23) affects from a traumatic event related to their health: responses ranging from 1=always to 5=never.
Total emotional domain score ranges from 23 to 115.
The higher the score the less impact the cardiac disease has on emotional health.
|
9 months after baseline visit
|
Social domain of Cardiac Quality of Life Survey assessed 9 months after baseline as compared to baseline.
Time Frame: 9 months after baseline visit
|
The social domain of the Cardiac Quality of life survey assesses social interaction and relationships.
10 questions. 1) Overall social interaction and relationships: responses ranging from 1=very poor to 5=very good.
2) Effect of heart disease-related physical limitations on social interaction: responses ranging from 1=always to 5=never.
3-10) Confidence in social interaction with friends and family: responses ranging from 1=always to 5=never.
Total social domain score ranges from 10 to 50.
The higher the score, the less impact the cardiac disease has on social health.
|
9 months after baseline visit
|
Spiritual domain of quality of life assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Time Frame: 9 months after baseline visit
|
The spiritual domain of the Cardiac Quality of life survey assesses attitudes patients have surrounding their faith and health status. 4 questions.
One question asks about if one's faith helps in coping with heart-related problems with responses ranging from 1=strongly disagree to 5=strongly agree.
Three questions ask about feelings of anger, injustice, and turmoil related to heart disease with responses ranging from 1=strongly agree to 5=strongly disagree.
Total spiritual domain score ranges from 4 to 20.
The higher the score, the less impact the cardiac disease has on spiritual health.
|
9 months after baseline visit
|
Self-efficacy assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Time Frame: 9 months after baseline visit
|
The self-efficacy domain of the Cardiac Quality of Life survey measures self-efficacy as it relates to symptoms of heart disease.
Six questions from the Cardiac Self-Efficacy Questionnaire asks about confidence in controlling symptoms, controlling illness, and maintaining daily functioning with responses ranging from 1=strongly disagree to 5=strongly agree.
Total self-efficacy score ranges from 6 to 30.
The higher the score, the less impact the cardiac disease has on self-efficacy.
|
9 months after baseline visit
|
Resilience assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Time Frame: 9 months after baseline visit
|
The resilience domain of the Cardiac Quality of Life survey measures the ability to recover quickly from difficulties.
9 questions asking about adapting to change, coping with stress, overcoming obstacles, and handling unpleasant feelings with responses ranging from 1=strongly disagree to 5=strongly agree.
Total resilience score ranges from 9 to 45.
The higher the score, more resilient the participant is in facing problems related to cardiac disease.
|
9 months after baseline visit
|
Impact of heritability of cardiac disease assessed 9 months after baseline visit as compared to the baseline survey in the outpatient clinic.
Time Frame: 9 months after baseline visit
|
Patients with thoracic aortic aneurysm or hypertrophic cardiomyopathy were asked questions about how the heritability of their cardiac disease affected their quality of life.
3 questions asking about how heritable cardiac disease affects the health and happiness of family members with responses ranging from 1=always to 5=never.
Total score ranges from 3 to 15.
The higher the score, the less impact the heritability of the cardiac disease as on the quality of life of the patient.
|
9 months after baseline visit
|
Impact of radiation-induced heart disease (RIHD) assessed at baseline visit in the outpatient clinic.
Time Frame: Baseline visit
|
RIHD patients are asked about radiation therapy history, awareness of risk of RIHD, and impact on QOL. 7 questions.
One question asks about time since last radiation therapy, ranging from 1= less than 5 years ago to 5=more than 30years ago.
Another asks about time since RIHD diagnosis, ranging from 1=within the past week to 5=more than five years ago.
One question asks about the duration of time between the symptoms of RIHD and diagnosis of RIHD with responses ranging from 1= less than 1 month to 5=more than 1 year.
One question asks about the awareness of risk of RIHD before radiation therapy with responses ranging from 1=strongly disagree to 5=strongly agree.
These four questions were not totaled.
Three questions ask about the overall QOL before and after RIHD diagnosis and after treatment for RIHD.
Responses ranged from 1=very poor to 5=very good.
Total score for this section ranges from 3 to 15 with a higher score indicating RIHD had less of an impact on the overall QOL.
|
Baseline visit
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Milind Desai, M. D., The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-1007
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
Linkoeping UniversityRecruiting
Clinical Trials on QOL Survey
-
University of Wisconsin, MadisonUniversity of British Columbia; University of California, San Diego; McGill University and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterCompletedLung Cancer | Non-small Cell Lung CancerUnited States
-
Stanford UniversityTerminatedHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Neuroendocrine Tumors | Cholangiocarcinoma | Gastrointestinal Cancer | GIST, MalignantUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoEuropean Leukemia Net; CML Advocates NetworkUnknownChronic Myeloid LeukemiaItaly, France, Germany, Spain
-
Centre Hospitalier Universitaire de BesanconDirection Générale de l'Offre de SoinsNot yet recruiting
-
M.D. Anderson Cancer CenterWithdrawn
-
University Hospital OstravaRecruitingMultiple Sclerosis | Lower Urinary Tract SymptomsCzechia
-
British Columbia Cancer AgencyRecruiting
-
Chinese University of Hong KongRecruitingStroke | Brain Diseases | Health Attitude | Brain Ischemia | Dementia | Alzheimer Disease | Healthy Aging | Stroke, Ischemic | Stroke, Acute | Health Knowledge, Attitudes, Practice | Health Personnel Attitude | Stroke SyndromeHong Kong
-
MediWound LtdCompletedQuality of Life | Scars FormationSlovakia